Chronic Obstructive Pulmonary Disease (Chronic Bronchitis,Amphysema). simple and mucopurulent chronic bronchitis,Emphysema
Conditions
Interventions
Intervention 1: Intervention 1: the training was performed using a volumetric exercisers (Respiflo
Tyco Health Care Ltd
UK)/ 10 to 15 times in two sessions of 15 minutes each morning and in the afternoon /4 days a week for 4 weeks. Intervention 2: Intervention2: the training was performed using a threshold inspiratory
Gaiam Ltd
Southam, Warwickshire, UK)/ daily in two sessions of 15 minute each morning and in the afternoon/4 days a week, for 4 weeks.
Rehabilitation
Intervention 1: the training was performed using a volumetric exercisers (Respiflo
UK)/ 10 to 15 times in two sessions of 15 minutes each morning and in the afternoon /4 days a week for 4 weeks.
Intervention2: the training was performed using a threshold inspiratory muscle trainer (POWERbreathe
Sponsors
Mashhad University of Medical Sciences, Research Section
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Obtaining informed consent, The chronic obstructive pulmonary disease diagnosed and confirmed by lung specialist and through paraclinical tests; fev1<80% predicted and fev1/fvc<70% (stageII, stable patients); clear Lungs, age 40-65; basic spirometry other than "Asthma"; No smoking at least for 3 months Exclusion criteria: Refuse to participate in research; not taking part in training for 4 weeks prior to the study; fever or respiratory infection; Respiratory or cardiac failure
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximal Voluntary Ventilation. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: L/m, by Hi 801 spirometer.;PImax. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: Cm/H20, mouth pressure meter.;Forced Vital Capasity. Timepoint: before intervention, end of week 2,end of week 4. Method of measurement: L, by Hi 801 spirometer.;Peek Expiratory Flow Rate. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: L/s, by Hi 801 spirometer.;Forced Expiratory Volume in One Second. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: L, by Hi 801 spirometer.;Tidal Volume. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: L, by Hi 801 spirometer.;Respiratory Rate. Timepoint: before intervention, end of week 2, end of week 4. Method of measurement: Count chest rising and coming down for one full minute, by watch OMax. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnea. Timepoint: befor intervention, end of week 2, end of week4. Method of measurement: Numerical Rating Scale (0-10).;Respiratory pattern. Timepoint: before intervention, end of week 2. end of week 4. Method of measurement: with measuring depth of respiration (according to tidal volume, L) and respiratory rate by watch, Breath/minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Heidary, Ph.D, Assistant professor of Mashhad University of Nursing and Midwifery
Mashhad University of Nursing and midwifery
Outcome results
None listed